Logo
Euro Gen MOTS C, 5mg

Euro Gen MOTS C, 5mg

Euro-Gen

Peptides
  • Manufactured and supplied within a research Use Only framework; it is not authorised as a medicinal product or medical device under MHRA or EMA regulations.
  • Express Peptides states that its peptides are manufactured in the UK with a minimum purity of >99% and are subject to third Party analytical testing, with Certificates of Analysis available on request.
  • Suppliers state compliance with general standards for research chemicals, including appropriate batch documentation and temperature Controlled handling from production to dispatch, but do not claim GMP certification for clinical use.
  • Product pages include prominent legal disclaimers that all peptides are for in vitro testing and laboratory research only and that any form of bodily introduction into humans or animals is prohibited.
Research peptide \u2013 mitochondrial-derived peptide MOTS-c

Description

Euro-Gen MOTS C, 5mg is a UK-manufactured research-grade peptide containing MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c), a 16-amino-acid mitochondrial-derived peptide encoded by the mitochondrial genome. It is studied in preclinical and in vitro research for its roles in metabolic regulation, insulin sensitivity, mitochondrial function, cellular stress responses, and aging biology. The product is presented as a 5 mg vial under the Euro-Gen Peptides brand and is explicitly designated for in vitro testing and laboratory research only, with supplier labelling that prohibits any form of administration to humans or animals and states that it is not a drug, food, cosmetic, or medicinal product.

Bnefits

  • Provides a defined research-grade source of MOTS-c, a mitochondrial-derived peptide encoded from the 12S rRNA region, enabling controlled studies of mitochondrial signalling and metabolic regulation.
  • Supplied as a 5 mg Euro-Gen branded vial, allowing reproducible dosing and standardisation in cell culture and other in vitro experimental designs.
  • Offered by a UK-based peptide supplier that states a minimum purity of >99% for its peptide range with batch-specific third-party analytical testing and Certificates of Analysis available on request.
  • Supported by extensive preclinical literature on MOTS-c in areas such as insulin sensitivity, glucose metabolism, fatty acid oxidation, stress-response signalling, and aging-related pathways, providing a strong scientific context for laboratory investigations.
  • Clearly labelled and marketed strictly for research use only, helping to ensure it is not confused with licensed medicinal products or clinical therapies.

Indications

  • In vitro and preclinical research into MOTS-c biology, including its role as a mitochondrial-derived peptide encoded by the 12S rRNA region.
  • Experimental studies on metabolic regulation, including insulin sensitivity, glucose uptake, fatty acid oxidation, and AMPK-related signalling pathways in cell and tissue models.
  • Laboratory investigations into mitochondrial function, cellular energy homeostasis, and stress-response signalling in the context of aging and longevity research.
  • Preclinical research on MOTS-c in models of obesity, type 2 diabetes, metabolic syndrome, and related cardiometabolic disorders.
  • Non-clinical studies exploring the potential roles of MOTS-c in cardiovascular, neurological, oncological, or musculoskeletal research, within appropriate laboratory systems.
  • Method development, assay validation, and mechanistic experiments involving MOTS-c in molecular biology, biochemistry, and cell biology laboratories.

Composition

  • Active component: synthetic MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) peptide, 5 mg per vial.
  • Chemical formula for MOTS-c reported by the supplier: C101H152N28O22S2.
  • Synonym / registry identifier referenced by the supplier: CAS 1627580-64-6.
  • No specific excipients, bulking agents, or stabilisers are disclosed on the product page.

Formulation

  • Supplied as a Euro-Gen MOTS C 5 mg vial intended for reconstitution prior to use in laboratory experiments.
  • Designated as a research-use-only peptide for in vitro testing and other non-clinical applications; no formulation for therapeutic or cosmetic use is provided.
  • No diluent or bacteriostatic water is included with the vial; appropriate solvent must be sourced separately by the researcher in line with institutional protocols.
  • Physical state is not explicitly described for this product on the seller page, but MOTS-c is typically supplied as a solid or lyophilised peptide suitable for solution preparation in sterile water or appropriate buffers.

Packaging

  • Single Euro-Gen branded vial containing 5 mg MOTS-c, labelled "MOTS C" with research-use-only warnings.
  • Primary container: sealed vial suitable for cold-chain storage and shipment as a research peptide reagent.
  • Sold individually via Express Peptides as "Euro-Gen MOTS C, 5mg" and also offered in a separate "MOTS C Pre-mixed Pen Injector, 5mg" presentation for research use.
  • Secondary packaging details (box materials, inserts) are not specified by the distributors.

Usage

  • For research and in vitro laboratory use only; not for human or veterinary use, injection, ingestion, inhalation, or topical application.
  • Handle only by suitably qualified professionals in an appropriate laboratory setting, following local regulations, institutional guidelines, and standard operating procedures for research peptides.
  • Reconstitute the peptide with a suitable sterile solvent (e.g., sterile water for injection or an appropriate buffer) under aseptic conditions, as defined by the laboratory’s protocols; gently mix to dissolve and avoid vigorous agitation that could denature the peptide.
  • Prepare working solutions at concentrations appropriate for the planned experimental system (cell culture, biochemical assays, etc.) and use aseptic technique to prevent contamination.
  • Record batch number, reconstitution details (solvent, concentration, date), and storage conditions for each preparation to support experimental reproducibility and quality control.
  • Dispose of any unused solutions and materials as chemical/biological research waste in accordance with institutional and regulatory requirements.
  • Do not use this product in any clinical, diagnostic, or cosmetic context and do not attempt to determine or follow human or animal dosing regimens, as none are authorised or provided.

Contraindications

  • Any use involving administration to humans or animals (e.g., injection, ingestion, inhalation, or topical application) is contraindicated and expressly prohibited by the supplier.
  • Not to be used as a medicinal product, cosmetic, food, dietary supplement, or diagnostic agent.
  • Must not be used outside appropriate laboratory facilities or by untrained personnel.
  • Use is contraindicated in any context that would contravene local, national, or international regulations governing unlicensed medicinal products, research chemicals, or controlled substances.
  • Should not be repackaged, relabelled, or marketed in any way that implies clinical approval, therapeutic indication, or cosmetic use.

Adverse Effects

  • No clinical adverse-effect profile is defined, as the product is not intended or licensed for administration to humans or animals.
  • Any toxicological or off-target effects must be evaluated within controlled experimental systems and cannot be assumed to predict safety in humans or other species.
  • Potential laboratory hazards relate to accidental exposure (e.g., skin contact, inhalation of aerosols, eye contact) and should be mitigated by adherence to standard laboratory safety procedures, including appropriate personal protective equipment (PPE).
  • Spills, aerosols, or accidental exposures should be managed according to institutional chemical/biological safety protocols, with medical evaluation for staff if exposure is suspected.

Storage Conditions

  • Follow general research-peptide handling guidelines: lyophilised or solid MOTS-c is typically stable for short periods at room temperature but should be stored at approximately −20 °C or below for long-term stability, protected from light and moisture.
  • Once reconstituted, store MOTS-c solutions at 2–8 °C for short-term use and avoid repeated freeze–thaw cycles, which can degrade peptide integrity.
  • Keep vials tightly closed when not in use and minimise time spent at ambient temperatures during handling.
  • Store out of the reach of unauthorised personnel and maintain appropriate inventory, labelling, and documentation consistent with institutional requirements for research chemicals.
  • Discard any solutions that show visible particulate matter, discolouration, or are kept beyond lab-validated stability periods.

Duration

Not applicable \u2013 Euro-Gen MOTS C, 5mg is a research-use-only peptide with no authorised clinical treatment regimen or duration.

Onset

Not applicable \u2013 no onset-of-effect data are established for human or veterinary use; available information relates only to preclinical and in vitro research models.

Browse more Peptides

Top Treatments

Top Cities in the UK